TickerFactsScreenerDevelopers

Ultragenyx Pharmaceutical Inc. (RARE) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2013: $9.54M2014: $13.02M2015: $28.48M2016: $66.65M2017: $107.30M2018: $110.65M2019: $481.73M2020: $605.18M2021: $599.84M2022: $1.19B2023: $1.22B2024: $1.24B2025: $1.60B$1.60B
2013Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$1.60B+29.3%
2024$1.24B+2.1%
2023$1.22B+1.9%
2022$1.19B+98.9%
2021$599.84M-0.9%
2020$605.18M+25.6%
2019$481.73M+335.4%
2018$110.65M+3.1%
2017$107.30M+61.0%
2016$66.65M+134.0%
2015$28.48M+118.7%
2014$13.02M+36.5%
2013$9.54M—